BioVersys' Series A Round

BioVersys raised a round of funding on June 27, 2013.

BioVersys is a biopharmaceutical company committed to delivering long term value to patients and investors by developing new therapies to combat antimicrobial drug resistance, a major unmet medical ne…

Articles about BioVersys' Series A Round: